- Home
- BKYI vs XYLO Comparison
BKYI vs XYLO Comparison
Compare BKYI & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKYI
- XYLO
- Stock Information
- Founded
- BKYI 1993
- XYLO 1999
- Country
- BKYI United States
- XYLO Israel
- Employees
- BKYI N/A
- XYLO N/A
- Industry
- BKYI Computer Software: Prepackaged Software
- XYLO
- Sector
- BKYI Technology
- XYLO
- Exchange
- BKYI Nasdaq
- XYLO NYSE
- Market Cap
- BKYI 3.2M
- XYLO 3.1M
- IPO Year
- BKYI 1997
- XYLO N/A
- Fundamental
- Price
- BKYI $1.73
- XYLO $4.73
- Analyst Decision
- BKYI
- XYLO
- Analyst Count
- BKYI 0
- XYLO 0
- Target Price
- BKYI N/A
- XYLO N/A
- AVG Volume (30 Days)
- BKYI 11.1M
- XYLO 16.2K
- Earning Date
- BKYI 11-14-2024
- XYLO 09-20-2024
- Dividend Yield
- BKYI N/A
- XYLO N/A
- EPS Growth
- BKYI N/A
- XYLO N/A
- EPS
- BKYI N/A
- XYLO N/A
- Revenue
- BKYI $7,292,394.00
- XYLO $57,642,000.00
- Revenue This Year
- BKYI $1.96
- XYLO $16.76
- Revenue Next Year
- BKYI $9.65
- XYLO $5.71
- P/E Ratio
- BKYI N/A
- XYLO N/A
- Revenue Growth
- BKYI N/A
- XYLO N/A
- 52 Week Low
- BKYI $0.52
- XYLO $2.70
- 52 Week High
- BKYI $3.68
- XYLO $9.07
- Technical
- Relative Strength Index (RSI)
- BKYI 54.73
- XYLO 61.62
- Support Level
- BKYI $1.31
- XYLO $4.19
- Resistance Level
- BKYI $3.68
- XYLO $4.88
- Average True Range (ATR)
- BKYI 0.58
- XYLO 0.49
- MACD
- BKYI 0.04
- XYLO 0.04
- Stochastic Oscillator
- BKYI 23.53
- XYLO 75.54
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About XYLO XYLO TECHNOLOGIES LTD
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.